Business Standard

Bal Pharma consolidated net profit declines 14.63% in the September 2016 quarter

Image

Capital Market

Sales rise 16.09% to Rs 64.88 crore

Net profit of Bal Pharma declined 14.63% to Rs 1.75 crore in the quarter ended September 2016 as against Rs 2.05 crore during the previous quarter ended September 2015. Sales rose 16.09% to Rs 64.88 crore in the quarter ended September 2016 as against Rs 55.89 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales64.8855.89 16 OPM %6.528.18 -PBDT3.423.96 -14 PBT2.002.44 -18 NP1.752.05 -15

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 15 2016 | 5:43 PM IST

Explore News